Key Events This Week
09 Feb: Stock opens steady at Rs.131.00 with no price change
10 Feb: Sharp 6.11% jump to Rs.139.00 on rising volumes
11 Feb: Quarterly results released; stock gains 0.83% to Rs.140.15
12 Feb: Profit-taking triggers 3.32% decline to Rs.135.50
13 Feb: Continued selling pressure drops stock 3.69% to close at Rs.130.50
09 February 2026: Week Opens Steady Amid Broader Market Gains
Reliance Chemotex Industries Ltd began the week unchanged at Rs.131.00, with a volume of 108 shares traded. This flat start contrasted with the Sensex’s robust 1.04% gain to 37,113.23, reflecting broader market optimism. The stock’s inactivity on this day suggested cautious positioning ahead of the company’s quarterly results announcement scheduled for 11 February.
10 February 2026: Strong Rally on Rising Volumes
The stock surged 6.11% to Rs.139.00 on increased volume of 471 shares, outperforming the Sensex’s modest 0.25% gain. This sharp move indicated growing investor interest, possibly in anticipation of positive earnings or operational updates. The price action set the stage for the quarterly results day, with the stock nearing its weekly high.
Our latest monthly pick, this Small Cap from Oil Exploration/Refineries, is showing strong performance since announcement! See why our Investment Committee chose it after screening 50+ candidates.
- - Investment Committee approved
- - 50+ candidates screened
- - Strong post-announcement performance
11 February 2026: Quarterly Results Reveal Flat Sales but Margin Strength
Reliance Chemotex reported a flat quarterly performance for the period ended December 2025, with net sales declining to ₹81.94 crores, the lowest in recent quarters. Despite this, the company posted a 59.55% increase in profit after tax over the nine-month period, reaching ₹3.51 crores, signalling effective cost control and operational efficiencies.
The stock responded positively, closing at Rs.140.15, up 0.83% from the previous day’s close, and hitting the week’s high. Intraday volatility was notable, with a high of Rs.149.30 and a low of Rs.139.00, reflecting mixed investor reactions to the earnings details. The company’s financial trend score dropped from 6 to 0, indicating a shift from growth to flat performance, primarily due to the sales contraction.
Comparatively, the Sensex edged up 0.13% to 37,256.72, underscoring Reliance Chemotex’s relative outperformance on the day.
12 February 2026: Profit-Taking Triggers Price Correction
Following the earnings announcement, the stock experienced profit-taking, declining 3.32% to Rs.135.50 on a volume of 1,675 shares. This retreat came amid a broader market pullback, with the Sensex falling 0.56% to 37,049.40. The price correction reflected investor caution given the flat sales and the challenges highlighted in the quarterly report, despite margin improvements.
Holding Reliance Chemotex Industries Ltd from ? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!
- - Peer comparison ready
- - Superior options identified
- - Cross market-cap analysis
13 February 2026: Continued Selling Pressure Ends Week Lower
The stock closed the week at Rs.130.50, down 3.69% on heavy volume of 5,625 shares, marking the lowest close of the week. This decline outpaced the Sensex’s 1.40% drop to 36,532.48, reflecting intensified selling pressure possibly driven by concerns over the company’s flat sales and uncertain near-term outlook. The week’s final session underscored the cautious sentiment prevailing among investors despite the company’s margin gains.
| Date | Stock Price | Day Change | Sensex | Day Change |
|---|---|---|---|---|
| 2026-02-09 | Rs.131.00 | +0.00% | 37,113.23 | +1.04% |
| 2026-02-10 | Rs.139.00 | +6.11% | 37,207.34 | +0.25% |
| 2026-02-11 | Rs.140.15 | +0.83% | 37,256.72 | +0.13% |
| 2026-02-12 | Rs.135.50 | -3.32% | 37,049.40 | -0.56% |
| 2026-02-13 | Rs.130.50 | -3.69% | 36,532.48 | -1.40% |
Key Takeaways from the Week
Positive Signals: The company demonstrated strong profitability gains with a 59.55% increase in PAT over nine months, reflecting effective cost management despite a challenging sales environment. The stock outperformed the Sensex on the days surrounding the quarterly results, indicating some investor confidence in margin resilience.
Cautionary Signals: The quarterly net sales decline to ₹81.94 crores marks a significant slowdown, with the financial trend score dropping from 6 to 0. The stock’s retreat in the latter half of the week on heavy volumes suggests investor concerns about sustaining growth amid volatile market conditions and sector headwinds.
Overall, Reliance Chemotex’s week was characterised by a midweek rally on earnings optimism followed by profit-taking and cautious sentiment, resulting in a slight weekly decline but relative outperformance versus the broader market.
Conclusion
Reliance Chemotex Industries Ltd’s week encapsulated the challenges of balancing flat revenue growth with improved profitability. While the company’s margin expansion offers some encouragement, the subdued sales and cautious investor response highlight ongoing risks. The stock’s modest 0.38% weekly decline, compared to the Sensex’s 0.54% fall, reflects a nuanced market view that values operational efficiency but remains wary of top-line pressures. Investors should monitor upcoming quarters closely for signs of sales recovery and sustained margin strength to better assess the company’s trajectory.
Unlock special upgrade rates for a limited period. Start Saving Now →
